Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer CEO Faces U.K. Panel as Resistance to Bid Hardens
Bloomberg
Monday, May 12, 2014 - 8:10am
tags:
Pfizer, UK, AstraZeneca, M&A, Ian Read
AstraZeneca CEO confident in pipeline of breakthrough drugs, Independent says
The Fly on the Wall
Monday, May 12, 2014 - 8:08am
tags:
Pascal Soriot, Pharma CEOs, AstraZeneca
U.K. Pursues More Guarantees From Pfizer Over AstraZeneca
Bloomberg
Sunday, May 11, 2014 - 11:34am
tags:
Pfizer, AstraZeneca, M&A
Got Dividend? This Biotech Just Initiated a Nearly 4% Yield!
Motley Fool
Sunday, May 11, 2014 - 11:32am
tags:
Theravance
Under fire, Pfizer hits back as it weighs next Astra move
Yahoo/Reuters
Sunday, May 11, 2014 - 11:31am
tags:
Pfizer, AstraZeneca, M&A
Immunomedics' (IMMU) CEO Cynthia Sullivan on F3Q 2014 Results - Earnings Call Transcript
Seeking Alpha
Sunday, May 11, 2014 - 10:48am
tags:
Immunomedics, earnings
UK labs play shrinking role in AstraZeneca drug portfolio
Reuters
Sunday, May 11, 2014 - 10:32am
tags:
AstraZeneca, R&D
Zalicus To Be Acquired By Epirus Biopharma
Seeking Alpha
Sunday, May 11, 2014 - 10:31am
tags:
Zalicus, Epirus
Gilead Announces Results from Phase 2 Study Showing Reduction in Atrial Fibrillation Burden with the Investigational Combination of Ranolazine and Low-Dose Dronedarone
Yahoo/BusinessWire
Sunday, May 11, 2014 - 10:30am
tags:
Gilead Sciences, dronedarone, ranolazine, atrial fibrilation
Pfizer Continues to Defend Takeover Bid for AstraZeneca
NY Times
Sunday, May 11, 2014 - 10:28am
tags:
Pfizer, M&A, AstraZeneca
This Week in Biotech: Chelsea Therapeutics Finds a Buyer While Corcept Implodes
Motley Fool
Saturday, May 10, 2014 - 12:45pm
tags:
Chelsea Therapeutics, Corcept Therapeutics, Lundbeck, Theravance, GSK, AstraZeneca, Amgen
Ranbaxy posts loss after write-offs on U.S. import bans
Reuters
Saturday, May 10, 2014 - 12:20pm
tags:
Ranbaxy, earnings
Teva sues FDA over bid to block approval of generic Copaxone
Live Mint
Saturday, May 10, 2014 - 12:17pm
tags:
Teva Pharmaceuticals, FDA, lawsuits, generics
RUTH SUNDERLAND: Why we must defend AstraZeneca from the £63bn takeover bid by Pfizer
This is Money, UK
Saturday, May 10, 2014 - 12:16pm
tags:
Pfizer, AstraZeneca, M&A
Plugging leaky blood vessels to save vision
Medical Xpress
Saturday, May 10, 2014 - 11:37am
tags:
sticky-trap
Pfizer’s Read Says AstraZeneca Deal Will Meet Scientific Needs
Bloomberg
Saturday, May 10, 2014 - 11:32am
tags:
Pfizer, AstraZeneca
Allergan Said to Be Rebuffed by Sanofi, J&J as It Seeks Bids
Bloomberg
Saturday, May 10, 2014 - 11:31am
tags:
Allergan, JNJ, Sanofi, M&A
Lilly Responds to Brazil Court Ruling in Labor Case
Yahoo/PR NewsWire
Saturday, May 10, 2014 - 10:52am
tags:
Eli Lilly, legal
Eli Lilly and Italian firm fined $450 mln for poisoning in Brazil
Reuters
Saturday, May 10, 2014 - 10:50am
tags:
Eli Lilly, legal
Amgen, AstraZeneca reports brodalumab study met primary, secondary endpoints
The Fly on the Wall
Saturday, May 10, 2014 - 10:48am
tags:
Amgen, AstraZeneca, brodalumab

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.